Cargando…

Single-Compartment Dose Prescriptions for Ablative (90)Y-Radioembolization Segmentectomy

Background: Yttrium-90 ((90)Y) radioembolization is increasingly being utilized with curative intent. While single-compartment doses with respect to the perfused volume for the complete pathologic necrosis (CPN) of tumors have been reported, the actual doses delivered to the tumor and at-risk margin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kappadath, Srinivas Cheenu, Lopez, Benjamin P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303682/ https://www.ncbi.nlm.nih.gov/pubmed/37374021 http://dx.doi.org/10.3390/life13061238

Ejemplares similares

Reassessment of the lung dose limits for radioembolization
por: Kappadath, S. Cheenu, et al.
Publicado: (2021)

Factors modulating (99m)Tc‐MAA planar lung dosimetry for (90)Y radioembolization
por: Lopez, Benjamin P., et al.
Publicado: (2022)

The physics of radioembolization
por: Bastiaannet, Remco, et al.
Publicado: (2018)

Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib
por: Teyateeti, Ajalaya, et al.
Publicado: (2021)

Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study
por: Kokabi, Nima, et al.
Publicado: (2023)

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
por: Teyateeti, Ajalaya, et al.
Publicado: (2020)

Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model
por: Henry, E. Courtney, et al.
Publicado: (2022)

A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
por: Lam, Marnix, et al.
Publicado: (2022)

Correction: Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model
por: Henry, E. Courtney, et al.
Publicado: (2023)

A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of (90)Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study
por: Mahvash, Armeen, et al.
Publicado: (2022)

Radioembolization with (90)Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy
por: Braat, A. J. A. T., et al.
Publicado: (2019)

Comparing voxel-based absorbed dosimetry methods in tumors, liver, lung, and at the liver-lung interface for (90)Y microsphere selective internal radiation therapy
por: Mikell, Justin K, et al.
Publicado: (2015)

Radioembolization and the Dynamic Role of (90)Y PET/CT
por: Pasciak, Alexander S., et al.
Publicado: (2014)

Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
por: Facciorusso, Antonio, et al.
Publicado: (2020)

Transarterial Radioembolization (TARE) Agents beyond (90)Y-Microspheres
por: Bouvry, C., et al.
Publicado: (2018)

Effects of voxel size and iterative reconstruction parameters on the spatial resolution of [Formula: see text] SPECT/CT
por: Kappadath, S. Cheenu
Publicado: (2011)

Determination of Radiation Absorbed Dose to Primary Liver Tumors and Normal Liver Tissue Using Post-Radioembolization (90)Y PET
por: Srinivas, Shyam M., et al.
Publicado: (2014)

Side Effects of Yttrium-90 Radioembolization
por: Riaz, Ahsun, et al.
Publicado: (2014)

Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases
por: Tsang, Erica S., et al.
Publicado: (2020)

Tumor response prediction in (90)Y radioembolization with PET-based radiomics features and absorbed dose metrics
por: Wei, Lise, et al.
Publicado: (2020)

Long-term outcome analysis of Y90 radioembolization in hepatocellular carcinoma
por: Lee, Hannah M., et al.
Publicado: (2023)

Simplification of dosimetry in (90)Y-radioembolization therapy by dual planar images
por: Abuqbeitah, Mohammad, et al.
Publicado: (2022)

Characterization of the energy response and backscatter contribution for two electronic personal dosimeter models
por: Meier, Joseph, et al.
Publicado: (2015)

Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated
por: De la Garza-Ramos, Cynthia, et al.
Publicado: (2021)

Yttrium-90 radioembolization of unresectable hepatocellular carcinoma – a single center experience
por: Meyer, Carsten, et al.
Publicado: (2017)

Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with (90)Y microspheres
por: Yim, Sun Young, et al.
Publicado: (2014)

Temporary Reversal of Hepatoenteric Collaterals during (90)Y Radioembolization Planning and Administration
por: Habibollahi, Peiman, et al.
Publicado: (2022)

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma
por: Yu, Chun-Yen, et al.
Publicado: (2023)

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
por: Lee, Victor Ho-Fun, et al.
Publicado: (2015)

Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
por: Kallini, Joseph Ralph, et al.
Publicado: (2016)

Internal dosimetry for radioembolization therapy with Yttrium‐90 microspheres
por: Fallahpoor, Maryam, et al.
Publicado: (2017)

History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma
por: Saini, Aman, et al.
Publicado: (2019)

Role of Yttrium-90 Radioembolization for Colorectal Hepatic Metastasis
por: Kim, Hyo-Cheol
Publicado: (2022)

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
por: Raval, Mihir, et al.
Publicado: (2014)

Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases: A Single Institution Experience
por: Nace, Gary W., et al.
Publicado: (2011)

Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization
por: D’Arienzo, Marco, et al.
Publicado: (2017)

Genomic mutations and histopathologic biomarkers in Y(90) radioembolization for chemorefractory colorectal liver metastases
por: Dendy, Meaghan S., et al.
Publicado: (2018)

(90)Y Radioembolization: Telemedicine During COVID-19 Outbreak, Opportunity for Prime Time
por: Quek, Lawrence, et al.
Publicado: (2020)

Post-embolization Syndrome Following Yttrium-90 Radiation Segmentectomy
por: Vanani, Naisarg B, et al.
Publicado: (2023)

Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry: round robin study on radioembolization treatment planning in hepatocellular carcinoma
por: Lam, Marnix, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_33kbkas6n9gkteqs1pnib9dg74